{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-285426","form_type":"8-K","ticker":"ALGS","cik":"0001799448","company_name":"Aligos Therapeutics, Inc.","filed_at":"2026-06-26T20:02:26+00:00","discovered_at":"2026-06-26T20:03:00.630744+00:00","generated_at":"2026-06-26T20:03:59.768379+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Aligos stockholders reelect two Class III directors, approve ESPP amendment adding 500K shares","bullets":["Bridget Martell and Carole Nuechterlein elected as Class III directors with 2,092,164 and 2,086,481 votes for, respectively.","Stockholders approved ESPP amendment increasing share reserve by 500,000 shares to 694,714 total, and eliminating evergreen provision.","Ratification of Ernst & Young as auditor for fiscal 2026 approved with 3,786,255 votes for.","Non-binding advisory say-on-pay approved with 2,074,434 votes for; company will hold future advisory votes annually.","Stockholders voted 2,077,884 for annual frequency of say-on-pay; board adopts annual vote until next advisory vote."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-285426","json":"https://secwatch.observer/filing/0001193125-26-285426.json","markdown":"https://secwatch.observer/filing/0001193125-26-285426.md","text":"https://secwatch.observer/filing/0001193125-26-285426.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799448/000119312526285426/0001193125-26-285426-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799448/000119312526285426/d70452d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T20:03:59.768379+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}